{"id":"W2896600825","doi":"10.1016/s1470-2045(18)30700-9","title":"Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial","year":2018,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1409,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Ono Pharmaceutical; Bristol-Myers Squibb","keywords":"Ipilimumab; Nivolumab; Medicine; Internal medicine; Oncology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003002837,0.001743852,0.002991277,0.000393988,0.0003877135,0.001412676,0.001170035,0.002018235,0.004666755],"category_scores_gemma":[0.002533619,0.0006652029,0.003564826,0.0003672662,0.001231366,0.001540654,0.0006387323,0.004321244,0.001026548],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001109391,"about_ca_system_score_gemma":0.0008640326,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001426132,"about_ca_topic_score_gemma":0.002850078,"domain_scores_codex":[0.9989017,0.0006663247,0.00004806115,0.0001735914,0.0000625976,0.0001475588],"domain_scores_gemma":[0.9986687,0.0005035638,0.0002844,0.0001151541,0.00005813583,0.0003701265],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9841275,0.001945246,0.0005567081,0.0003754981,0.001489071,0.00002100971,0.00003956338,0.0003567301,0.001150996,0.00007194017,0.0006418975,0.009223809],"study_design_scores_gemma":[0.9468643,0.04830842,0.002498664,0.000044031,0.001052334,0.00002799777,0.00002794036,0.000361023,0.0002294098,0.0001761786,0.0003915267,0.00001819051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9869451,0.006883196,0.0004862803,0.0009162442,0.0006652562,0.00124222,0.000955089,0.0000996176,0.001807025],"genre_scores_gemma":[0.9902418,0.002380492,0.001053218,0.0009745004,0.0004235962,0.001079814,0.001107645,0.00003522572,0.002703754],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004666755,"threshold_uncertainty_score":0.0158807,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.059457284228469,"score_gpt":0.3855917897477813,"score_spread":0.3261345055193123,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}